ABBOTT LABORATORIES acquired Piramal Healthcare Solutions (Piramal Healthcare's Healthcare Solutions business) for $2.2 billion up-front plus $400 million annually for four years beginning in 2011 (approximately $3.72 billion total), a transaction completed in September 2010, structured as all cash (up-front plus deferred payments). The deal was a Asset purchase.
Piramal Healthcare Solutions (Piramal Healthcare's Healthcare Solutions business) operates in Pharmaceuticals — branded generics (India), is based in Mumbai, India. Piramal's Healthcare Solutions business is a leading branded generics pharmaceutical operation in India with a broad product portfolio and extensive local distribution.
Propels Abbott to the top position in India with pharmaceutical sales expected to exceed $2.5 billion by 2020, establishing Abbott as the leading pharmaceutical company in India.
Top market position in the fast-growing Indian pharmaceutical market. Integrated into Abbott's Established Products / pharmaceutical business in India
Advisory firms were not disclosed for this transaction.